Genome-wide expression profiling in pediatric septic shock

Pediatric Research

Volumn 73, Issue 4-2, 2013, Pages 564-569

  Wong, Hector R ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; BIOINFORMATICS; CHILD; CRITICALLY ILL PATIENT; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; PEDIATRICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; SYSTEMS BIOLOGY; BIOLOGY; CRITICAL ILLNESS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INFANT; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; SHOCK, SEPTIC;

BIOMARKERS; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; CRITICAL ILLNESS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INFANT, NEWBORN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIATRICS; SHOCK, SEPTIC; SYSTEMS BIOLOGY;

EID: 84877346216     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.11     Document Type: Review

References (65)

1. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: defnitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
2. Wong HR. Clinical review: sepsis and septic shock-the potential of gene arrays. Crit Care 2012;16:204.
3. Cornell TT, Wynn J, Shanley TP, Wheeler DS, Wong HR. Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 2010;125:1248-58.
4. Wynn J, Cornell TT, Wong HR, Shanley T P, Wheeler DS. The host response to sepsis and developmental impact. Pediatrics 2010;125:1031-41.
5. Marshall JC. Sepsis: rethinking the approach to clinical research. J Leukoc Biol 2008;83:471-82.
6. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;306:2594-605.
7. Hotchkiss RS, Opal S. Immunotherapy for sepsis-a new approach against an ancient foe. N Engl J Med 2010;363:87-9.
8. Felmet KA, Hall MW, Clark RS, Jafe R, Carcillo JA. Prolonged lym-phopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005;174:3765-72.
9. Hall M W, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 2011;37:525-32.
10. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009;15:496-7.
11. Cvijanovich N, Shanley TP, Lin R, et al.; Genomics of Pediatric SIRS/Septic Shock Investigators. Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008;34:127-34.
12. Shanley T P, Cvijanovich N, Lin R, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007;13:495-508.
13. Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med 2012;40:1618-26.
14. Wong HR, Cvijanovich N, Allen GL, et al.; Genomics of Pediatric SIRS/Septic Shock Investigators. Genomic expression profling across the pedi-atric systemic infammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009;37:1558-66.
15. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley T P. Leukocyte subset-derived genomewide expression profles in pediatric septic shock. Pediatr Crit Care Med 2010;11:349-55.
16. Wong HR, Shanley T P, Sakthivel B, et al.; Genomics of Pediatric SIRS/Septic Shock Investigators. Genome-level expression profles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007;30:146-55.
17. Wynn JL, Cvijanovich NZ, Allen GL, et al. The infuence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 2011;17:1146-56.
18. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profling of human sepsis: a systematic review. Crit Care 2010;14:R237.
19. Tang BM, McLean AS, Dawes I W, Huang SJ, Cowley MJ, Lin RC. Gene-expression profling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008;36:1125-8.
20. Tang BM, McLean AS, Dawes I W, Huang SJ, Lin RC. The use of gene-expression profling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007;176:676-84.
21. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009;37:882-8.
22. Xiao W, Mindrinos MN, Seok J, et al.; Infammation and Host Response to Injury Large-Scale Collaborative Research Program. A genomic storm in critically injured humans. J Exp Med 2011;208:2581-90.
23. Unsinger J, McGlynn M, Kasten KR, et al. IL-7 promotes T cell viability, trafcking, and functionality and improves survival in sepsis. J Immunol 2010;184:3768-79.
24. Carcillo JA, Dean JM, Holubkov R, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med 2012;13:165-73.
25. Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol 2010;37:307-37.
26. Wynn JL, Scumpia PO, Winfeld RD, et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008;112:1750-8.
27. Cuenca AG, Wynn JL, Kelly-Scumpia KM, et al. Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect Immun 2011;79:2746-54.
28. Wynn JL, Scumpia PO, Delano MJ, et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 2007;28:675-83.
29. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 ampli-fes infammation and is a crucial mediator of septic shock. Nature 2001;410:1103-7.
30. Wong HR, Cvijanovich N, Lin R, et al. Identifcation of pediatric septic shock subclasses based on genome-wide expression profling. BMC Med 2009;7:34.
31. Wong HR, Cvijanovich NZ, Allen GL, et al. Validation of a gene expression-based subclassifcation strategy for pediatric septic shock. Crit Care Med 2011;39:2511-7.
32. Wong HR, Wheeler DS, Tegtmeyer K, et al. Toward a clinically feasible gene expression-based subclassifcation strategy for septic shock: proof of concept. Crit Care Med 2010;38:1955-61.
33. Standage S W, Caldwell CC, Zingarelli B, Wong HR. Reduced per-oxisome proliferator-activated receptor a expression is associated with decreased survival and increased tissue bacterial load in sepsis. Shock 2012;37:164-9.
34. Eichler GS, Huang S, Ingber DE. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profles. Bioinformatics 2003;19:2321-2.
35. Guo Y, Eichler GS, Feng Y, Ingber DE, Huang S. Towards a holistic, yet gene-centered analysis of gene expression profles: a case study of human lung cancers. J Biomed Biotechnol 2006;2006:69141.
36. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009;22:224-39, Table of Contents.
37. Solan PD, Dunsmore KE, Denenberg AG, Odoms K, Zingarelli B, Wong HR. A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 2012;40:379-87.
38. Lauhio A, Hästbacka J, Pettilä V, et al. Serum MMP-8,-9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011;64:590-4.
39. Fink M P. Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis. Crit Care Med 2012;40:655-6.
40. Prasad AS. Zinc: mechanisms of host defense. J Nutr 2007;137:1345-9.
41. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr 2008;32:509-19.
42. Besecker BY, Exline MC, Hollyfeld J, et al. A comparison of zinc metabolism, infammation, and disease severity in critically ill infected and non-infected adults early afer intensive care unit admission. Am J Clin Nutr 2011;93:1356-64.
43. Cvijanovich NZ, King JC, Flori HR, Gildengorin G, Wong HR. Zinc homeostasis in pediatric critical illness. Pediatr Crit Care Med 2009;10:29-34.
44. Knoell DL, Liu MJ. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int J Vitam Nutr Res 2010;80:271-7.
45. Bao S, Liu MJ, Lee B, et al. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2010;298:L744-54.
46. Knoell DL, Julian M W, Bao S, et al. Zinc defciency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit Care Med 2009;37:1380-8.
47. Nowak JE, Harmon K, Caldwell CC, Wong HR. Prophylactic zinc supplementation reduces bacterial load and improves survival in a murine model of sepsis. Pediatr Crit Care Med 2012;13:e323-9.
48. Srinivasan MG, Ndeezi G, Mboijana CK, et al. Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial. BMC Med 2012;10:14.
49. Bhatnagar S, Wadhwa N, Aneja S, et al. Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial. Lancet 2012;379:2072-8.
50. Marshall JC, Reinhart K; International Sepsis Forum. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8.
51. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011;12:165-73.
52. Standage S W, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ter 2011;9:71-9.
53. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratifca-tion tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008;178:276-82.
54. Calfee CS, Tompson BT, Parsons PE, Ware LB, Matthay MA, Wong HR. Plasma interleukin-8 is not an efective risk stratifcation tool for adults with vasopressor-dependent septic shock. Crit Care Med 2010;38:1436-41.
55. Wong HR, Salisbury S, Xiao Q, et al. The pediatric sepsis biomarker risk model. Crit Care 2012;16:R174.
56. Basu RK, Devarajan P, Wong H, Wheeler DS. An update and review of acute kidney injury in pediatrics. Pediatr Crit Care Med 2011;12:339-47.
57. Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008;36:1297-303.
58. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipoc-alin (NGAL) as a biomarker for acute renal injury afer cardiac surgery. Lancet 2005;365:1231-8.
59. Basu RK, Standage S W, Cvijanovich NZ, et al. Identifcation of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray. Crit Care 2011;15:R273.
60. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalci-tonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
61. Wong HR, Cvijanovich NZ, Hall M, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care 2012;16:R213.
62. Wojno ED, Hunter CA. New directions in the basic and translational biology of interleukin-27. Trends Immunol 2012;33:91-7.
63. Wirtz S, Tubbe I, Galle PR, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 2006;203:1875-81.
64. Sun L, Gorospe JR, Hofman EP, Rao AK. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profling. J Tromb Haemost 2007;5:146-54.
65. Nowak JE, Wheeler DS, Harmon KK, Wong HR. Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock. Pedi-atr Crit Care Med 2010;11:213-6.